Quarterly report [Sections 13 or 15(d)]

Basic and Diluted Loss Per Share (Tables)

v3.25.1
Basic and Diluted Loss Per Share (Tables)
 3 Months Ended
Mar. 31, 2025
Basic and Diluted Loss Per Share [Abstract]  
Schedule of Anti-dilutive Financial Instruments

The calculation of diluted loss per share for the three months ended March 31, 2025 and March 31, 2024, does not include the shares underlying the following financial instruments because their effect would be anti-dilutive:

 

    Three Months Ended
March 31,		  
    2025     2024  
Options     1,923,681       519,335  
Warrants     18,235,515       12,646,131  
Contingent shares     200,000       200,000  
Redeemable Convertible Preferred Shares     14,773,500        25,688,700    
Schedule of Basic and Diluted Loss (Earnings) Per Share

The following table presents the computation of basic and diluted loss (earnings) per share:

 

    Three Months Ended
March 31,		  
    2025     2024  
Basic and diluted loss per share of common stock            
Numerator:            
Net loss     7,659       17,327  
Denominator:                
Number of shares of common stock outstanding     20,770,361       5,245,684  
Number of shares upon pre-funded warrants and A&R Warrants exercise     2,332,445       983,245  
Number of shares upon Fully vested Warrants exercise     298       298  
Total weighted-average number of shares of common stock, shares upon pre-funded warrants, A&R Warrants and Fully
vested Warrants exercise used in computing basic and diluted loss per share		     23,103,105       6,229,228  
Basic and diluted loss per share of common stock     0.33       2.78